MedTrace Logo

Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

NCT03759743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2020-07-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Conditions

Interventions

DIETARY_SUPPLEMENT

LMT1-48

capsules containing Probiotics

DIETARY_SUPPLEMENT

Placebo

capsules that did not contain any probiotics

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2019-08-17
Completion
2020-01-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03759743 on ClinicalTrials.gov